From the AGM presentation:
Strong news flow for 2013 onwards….
• Ongoing communication
• Regular updates
Strong News Flow
Clinical development of TPM/oxycodone Q2/2013 ?
Clinical development of TPM/oxymorphone Q2/2013 ?
Expansion of TPM/diclofenac program with Nippon Zoki
(Japan)H2 /2013 ?
Strategic partnership for TPM Mastitis Project - USDA Q2/2013 ?
Novartis -Expansion of strategic partnership for
TPM/diclofenac Q2/2013 ?
Phase 2 TPM/retinoic acid (dermatology) Q3/2013
Phase 2 TPM/ketocanozole (dermatology) Q4/2013
Phase 2 TPM/oxycodone topical assessment Q3/2014
So based on that, they are not out of order. However, there is plenty more that needs explanation!
- Forums
- ASX - By Stock
- AVE
- good story badly told..
good story badly told.., page-81
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $4.366K | 1.455M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
62 | 90468113 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 60283238 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 86593113 | 0.002 |
22 | 73500009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 60283238 | 17 |
0.004 | 21966015 | 19 |
0.005 | 20469333 | 10 |
0.006 | 20865067 | 11 |
0.007 | 10865221 | 9 |
Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |